Using carcinoma cell lines derived from the PyMT mammary tumor model (20), we found a dramatic down-regulation of the antioxidant GPx2 in the highly metastatic PyMT2 relative to the weakly metastatic PyMT1 tumor cell line, which were representative of other cell lines derived from the same mammary tumor. This evidence concerns the gene GPX2 and breast cancer.